Home › Funds › Royce & Associates › ANIP
Royce & Associates position in ANIP
ANI PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)18.42K sh
Reported value held$1.52M
Portfolio Weight0.01%
First reportedQ1 2026
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 24.05K | $1.85M | New |
| Q2 2026 | 18.42K | $1.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANIP
- Vanguard Group 1.31M sh · $103.02M · Q4 2025
- Point72 Asset Management 47.85M sh · $62.02M · Q2 2026
- Arrowstreet Capital 562.02K sh · $46.52M · Q2 2026
- Geode Capital Management 536.41K sh · $44.41M · Q2 2026
- Millennium Management 507.21K sh · $41.99M · Q2 2026
- Deutsche Bank AG 323.44K sh · $26.77M · Q2 2026
- Invesco Ltd 309.23K sh · $25.60M · Q2 2026
- UBS Group AG 297.54K sh · $24.63M · Q2 2026
- Charles Schwab Investment Management 252.57K sh · $20.91M · Q2 2026
- BlackRock Inc 15.06M sh · $19.51M · Q2 2026
- Northern Trust Corp 209.16K sh · $17.31M · Q2 2026
- Bank of America Corp 183.07K sh · $15.15M · Q2 2026